BenchSci Analysis: $158M Raised
What is BenchSci?
BenchSci is a leader in AI solutions for preclinical research and development. Their ASCEND platform uniquely integrates a knowledge graph and ontological knowledge base to enhance decision-making in biomedical research. This approach significantly improves experimental productivity and uncovers novel insights into disease biology.
Employees
201-500
Founded
2015
Industry
SaaS, AI/ML, HealthTech
Product Features & Capabilities
- ASCEND AI platform for disease biology research
- Proprietary ontology knowledge base for evidence mapping
- Multi-modal AI for data harmonization
- Specialized AI assistants for pharma workflows
- Enterprise integrations for internal data and reporting.
Use Cases
Guide scientists in experimental design and decision-making; Decode complex biomedical data from literature; Enhance productivity in preclinical research; Generate innovative research ideas; Support drug discovery processes in pharma.
How much BenchSci raised
Series D - $95 million
May 25, 2023Lead Investor: Generation Investment Management, Inovia Capital, TCV, Golden Ventures, F-Prime Capital
Series C - $63 million
January 24, 2022Lead Investor: Inovia Capital, TCV
Other Considerations
Raised $95 million in Series D funding; Serves major pharmaceutical companies; Focused on integrating internal and external data sources.
See something that needs updating? Suggest edits to this profile.